Digital Relevance and impact: Connecting with HCPs in the digital ag... What’s the best way to influence physician behaviour? This is the pharmaceutical industry’s billion-dollar question.
Patients Could virtual wards be the answer to NHS waiting lists? Hospitals across the UK are under pressure from increasing numbers of admissions year on year and an estimated 7.2 million people – one in eight of England’s population – are on a waiting l
R&D Precision, speed, impact: Evolving mass spectrometry for med... MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
